145 related articles for article (PubMed ID: 17875095)
1. Toxic epidermal necrolysis in a child successfully treated with cyclosporin A and methylprednisolone.
Aihara Y; Ito R; Ito S; Aihara M; Yokota S
Pediatr Int; 2007 Oct; 49(5):659-62. PubMed ID: 17875095
[No Abstract] [Full Text] [Related]
2. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced toxic epidermal necrolysis treated with cyclosporin.
Renfro L; Grant-Kels JM; Daman LA
Int J Dermatol; 1989 Sep; 28(7):441-4. PubMed ID: 2777442
[TBL] [Abstract][Full Text] [Related]
4. Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers.
Hirahara K; Kano Y; Sato Y; Horie C; Okazaki A; Ishida T; Aoyama Y; Shiohara T
J Am Acad Dermatol; 2013 Sep; 69(3):496-8. PubMed ID: 23957982
[No Abstract] [Full Text] [Related]
5. Systemic and local management at the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Kinoshita S
Am J Ophthalmol; 2010 Feb; 149(2):354; author reply 355. PubMed ID: 20103059
[No Abstract] [Full Text] [Related]
6. Toxic epidermal necrolysis treated with cyclosporin.
Hewitt J; Ormerod AD
Clin Exp Dermatol; 1992 Jul; 17(4):264-5. PubMed ID: 1451317
[TBL] [Abstract][Full Text] [Related]
7. FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis.
Morgado-sCarrasco D; Fustà-Novell X; Iranzo P
Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):601-603. PubMed ID: 30971332
[No Abstract] [Full Text] [Related]
8. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
9. Treatment of toxic epidermal necrolysis with cyclosporin A.
Arévalo JM; Lorente JA; González-Herrada C; Jiménez-Reyes J
J Trauma; 2000 Mar; 48(3):473-8. PubMed ID: 10744287
[TBL] [Abstract][Full Text] [Related]
10. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
[TBL] [Abstract][Full Text] [Related]
11. Toxic epidermal necrolysis associated with severe hypocalcaemia, and treated with cyclosporin.
Zaki I; Patel S; Reed R; Dalziel KL
Br J Dermatol; 1995 Aug; 133(2):337-8. PubMed ID: 7547417
[No Abstract] [Full Text] [Related]
12. [Toxic epidermal necrolysis treated with cyclosporin A].
Carmona AF; Redondo AD; Peña LO; Gómez AG; Pareja JC; Martínez JL
Med Intensiva; 2011 Oct; 35(7):442-5. PubMed ID: 21215491
[TBL] [Abstract][Full Text] [Related]
13. Intravenous cyclosporine in treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis: A case series.
Vinay K; Kaushik A; Kumaran MS; Parsad D
Dermatol Ther; 2019 Jul; 32(4):e12957. PubMed ID: 31070856
[No Abstract] [Full Text] [Related]
14. Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'.
Dumas M; Hua C; Hotz C; Velter C; Duong TA; Maraffi T; Ortonne N; Hüe S; Fardet L; de Prost N; Wolkenstein P; Ingen-Housz-Oro S; Chosidow O
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):e360-e361. PubMed ID: 29524279
[No Abstract] [Full Text] [Related]
15. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy".
Sherertz EF; Jegasothy BV; Lazarus GS
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 2):178-81. PubMed ID: 3973116
[TBL] [Abstract][Full Text] [Related]
16. Suprapharmacologic doses of intravenous dexamethasone followed by cyclosporine in the treatment of toxic epidermal necrolysis.
Rai R; Srinivas CR
Indian J Dermatol Venereol Leprol; 2008; 74(3):263-5. PubMed ID: 18583801
[No Abstract] [Full Text] [Related]
17. Acute management of Stevens-Johnson syndrome and toxic epidermal necrolysis to minimize ocular sequelae.
Tseng SC
Am J Ophthalmol; 2009 Jun; 147(6):949-51. PubMed ID: 19463535
[No Abstract] [Full Text] [Related]
18. New Evidence Supporting Cyclosporine Efficacy in Epidermal Necrolysis.
Roujeau JC; Mockenhaupt M; Guillaume JC; Revuz J
J Invest Dermatol; 2017 Oct; 137(10):2047-2049. PubMed ID: 28941473
[TBL] [Abstract][Full Text] [Related]
19. Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Shah R; Chen ST; Kroshinsky D
J Am Acad Dermatol; 2021 Aug; 85(2):512-513. PubMed ID: 30630021
[No Abstract] [Full Text] [Related]
20. [Reply to the article "treatment of toxic epidermal necrolysis with cyclosporine A"].
Cachafeiro L; Sánchez M; Leyva F; García de Lorenzo A
Med Intensiva; 2012; 36(5):382. PubMed ID: 22560154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
